Logo image
Part 2: Making the “unproven” “proven"
Journal article   Peer reviewed

Part 2: Making the “unproven” “proven"

D.J. Weiss, J.E.J. Rasko, N. Cuende, M.A. Ruiz, H-N Ho, R. Nordon, S. Wilton, M. Dominici and A. Srivastava
Cytotherapy, Vol.18(1), pp.120-123
2016
url
Link to Published Version *Subscription may be requiredView

Abstract

The use of living, disaggregated cells in medicine involves a number of aspects that make this approach distinct from traditional pharmaceutical products. Cells are not metabolized by the liver or kidney, unlike most small-molecule drugs, but are potentially capable of distribution throughout the entire body. Cells are also highly complex and change dynamically in response to their environment and over time, making it difficult to standardize them in the same way that molecules can be engineered and mass-produced. Some type of cells may also secrete multiple bioactive molecules, such as cytokines and growth factors, as well as microvesicles, which may be released in different amounts or combinations, depending upon the cells' immediate environment or the pathophysiological state of the body into which they are introduced...

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.102 Stem Cell Research
1.102.110 Mesenchymal Stem Cells
Web Of Science research areas
Biotechnology & Applied Microbiology
Cell & Tissue Engineering
Cell Biology
Hematology
Medicine, Research & Experimental
ESI research areas
Biology & Biochemistry
Logo image